Gene · 9
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic atlas of GNAT family members in pulmonary epithelia under pathological conditions using single-cell and bulk cell sequencing. | Clin Transl Med | 2022 | 35858249 | PubTator, text mining | PubMed |
| Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing. | Front Pharmacol | 2022 | 35846994 | PubTator, text mining | PubMed |
| Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA. | Front Toxicol | 2022 | 35832492 | PubTator, text mining | PubMed |
| Melatonin and the Brain-Heart Crosstalk in Neurocritically Ill Patients-From Molecular Action to Clinical Practice. | Int J Mol Sci | 2022 | 35806098 | PubTator, text mining | PubMed |
| Breast Cancer Genomics: Primary and Most Common Metastases. | Cancers (Basel) | 2022 | 35804819 | PubTator, text mining | PubMed |
| The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review. | Pharmgenomics Pers Med | 2022 | 35795337 | PubTator, text mining | PubMed |
| Molecular and Functional Characterization of N-Acetyltransferases in Common Marmosets and Pigs. | Drug Metab Dispos | 2022 | 35768074 | PubTator, text mining | PubMed |
| High-sensitivity pattern discovery in large, paired multiomic datasets. | Bioinformatics | 2022 | 35758795 | PubTator, text mining | PubMed |
| Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development. | Acta Pharm Sin B | 2022 | 35755285 | PubTator, text mining | PubMed |
| The Alteration of m6A Modification at the Transcriptome-Wide Level in Human Villi During Spontaneous Abortion in the First Trimester. | Front Genet | 2022 | 35754822 | PubTator, text mining | PubMed |
| Condylar Changes after Maxillary Expansion in Children with Cleft Lip and Palate-A Three-Dimensional Retrospective Study. | Biomimetics (Basel) | 2022 | 35735589 | PubTator, text mining | PubMed |
| Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies. | ACS Omega | 2022 | 35721972 | PubTator, text mining | PubMed |
| Genetic Variants and Drug Efficacy in Tuberculosis: A Step toward Personalized Therapy. | Glob Med Genet | 2022 | 35707778 | PubTator, text mining | PubMed |
| Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences. | NPJ Breast Cancer | 2022 | 35697736 | PubTator, text mining | PubMed |
| Hexavalent chromium increases the metabolism and genotoxicity of aromatic amine carcinogens 4-aminobiphenyl and β-naphthylamine in immortalized human lung epithelial cells. | Toxicol Appl Pharmacol | 2022 | 35662664 | PubTator, text mining | PubMed |
| Hypercholesterolemia reduces the expression and function of hepatic drug metabolizing enzymes and transporters in rats. | Toxicol Lett | 2022 | 35654319 | PubTator, text mining | PubMed |
| The Promise of Nanotechnology in Personalized Medicine. | J Pers Med | 2022 | 35629095 | PubTator, text mining | PubMed |
| Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance. | Cells | 2022 | 35626710 | PubTator, text mining | PubMed |
| Three-Dimensional Organotypic Cultures Reshape the microRNAs Transcriptional Program in Breast Cancer Cells. | Cancers (Basel) | 2022 | 35626094 | PubTator, text mining | PubMed |
| A Systematic Review on Marine Algae-Derived Fucoxanthin: An Update of Pharmacological Insights. | Mar Drugs | 2022 | 35621930 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9/papers?page=10